iSpecimen Inc (ISPC)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.34
0.00 (0.00%)
After-Hours: 16:29
iSpecimen Revenue (Quarterly): 2.662M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.662M |
| June 30, 2024 | 2.864M |
| March 31, 2024 | 2.29M |
| December 31, 2023 | 2.575M |
| September 30, 2023 | 2.778M |
| June 30, 2023 | 1.625M |
| March 31, 2023 | 2.950M |
| December 31, 2022 | 2.962M |
| September 30, 2022 | 2.583M |
| June 30, 2022 | 2.339M |
| March 31, 2022 | 2.519M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.549M |
| September 30, 2021 | 2.718M |
| June 30, 2021 | 2.904M |
| March 31, 2021 | 2.964M |
| December 31, 2020 | 2.718M |
| September 30, 2020 | 2.250M |
| June 30, 2020 | 1.505M |
| March 31, 2020 | 1.712M |
| December 31, 2019 | 1.290M |
| September 30, 2019 | 0.6927M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.290M
Minimum
Dec 2019
2.964M
Maximum
Mar 2021
2.438M
Average
2.579M
Median
Revenue (Quarterly) Benchmarks
| RadNet Inc | 461.14M |
| 23andMe Holding Co | 44.07M |
| Delcath Systems Inc | 11.20M |
| CytoSorbents Corp | 8.613M |
| Progyny Inc | 286.62M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.440M |
| Total Expenses (Quarterly) | 4.367M |
| EPS Diluted (Quarterly) | -2.10 |
| Enterprise Value | 3.521M |
| Gross Profit Margin (Quarterly) | 41.62% |
| Profit Margin (Quarterly) | -54.09% |
| Earnings Yield | -440.6% |
| Normalized Earnings Yield | -440.55 |